Cargando…
Development of CAPER peptides for the treatment of triple negative breast cancer
Triple negative breast cancer (TNBC) is a heterogeneous disease, which lacks expression of the estrogen receptor (ER), progesterone receptor (PR) and the human epidermal growth factor 2 receptor (HER2). This subtype of breast cancer has the poorest prognosis with limited therapies currently availabl...
Autores principales: | Chilewski, Shannon D., Bhosale, Devyani, Dees, Sundee, Hutchinson, Isaac, Trimble, Rachel, Pontiggia, Laura, Mercier, Isabelle, Jasmin, Jean-Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100886/ https://www.ncbi.nlm.nih.gov/pubmed/31931653 http://dx.doi.org/10.1080/15384101.2020.1711579 |
Ejemplares similares
-
Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer
por: Dees, Sundee, et al.
Publicado: (2020) -
CAPER as a therapeutic target for triple negative breast cancer
por: Campbell, Mallory C., et al.
Publicado: (2018) -
Essential role of STAT5a in DCIS formation and invasion following estrogen treatment
por: Dees, Sundee, et al.
Publicado: (2020) -
Venezuelan Equine Encephalitis Virus Capsid—The Clever Caper
por: Lundberg, Lindsay, et al.
Publicado: (2017) -
Influence of Seed-Covering Layers on Caper Seed Germination
por: Foschi, María Laura, et al.
Publicado: (2023)